Weekly Briefing: Biotech, AI and data drive £142.4m in UK startup funding (16–20 Mar 2026)
🎧 Prefer to listen? Play this week's Startupmag Briefing below:
It's Friday, 20 March, and this is your Startupmag Weekly Briefing.
UK startups raised a combined £142.4m during 16–20 Mar 2026, led by big rounds in biotech, AI and data. The week saw clinical-stage biotech financings alongside AI and data plays scaling product and go-to-market.
Platform AI gains enterprise traction
Platform and productivity AI continued to attract funding this week as startups add governance, integrations and automation to enterprise workflows. Investors appear to be prioritising platform plays over point solutions, betting these layers will reduce operational risk and accelerate delivery across complex programmes.
Notable rounds underline that shift. Foresight raised £25 million to scale its AI-driven Predictive Project Delivery platform for large infrastructure programmes and to push into adjacent verticals such as power and defence. VerbaFlo secured £5.26 million to build an AI communications platform for real estate, automating leasing and resident engagement while funding US expansion and wider international rollout. xmemory took roughly £3.01 million to develop a precision memory layer aimed at improving AI reliability and governance, and Signals completed a £827,000 seed round to accelerate development of research integrity products that use metadata and AI.
Together these deals point to a London-centred cluster spanning proptech, creator workspaces and enterprise AI tooling. How firms sequence international roll-outs remains unclear, but the capital signals sustained investor appetite for integration and governance layers — and the likelihood of follow-on funding as enterprises demand scalable, auditable AI infrastructure.
This week's AI & Enterprise Software deals:
Foresight raised £25m in a Series A to scale its AI-driven Predictive Project Delivery platform for large infrastructure programmes. The funding will accelerate product development, expand global deployments and push into adjacent verticals such as power and defence.
VerbaFlo raised £5.3m to build its AI communications platform for real estate, automating leasing and resident engagement across channels. The seed round will fund US expansion, product development and wider international rollout.
xmemory raised roughly £3.01m pre-seed to develop a precision memory layer that improves AI reliability and governance. The funds will support pilots with design partners and further product development for enterprise AI workflows.
Signals raised £827k in seed funding to accelerate development of its research integrity products that use metadata and AI to verify academic work. The round brings strategic partnerships with publishers and will fund scaling of its data graph and AI capabilities.
Health and biotech — balancing deep R&D with practical healthtech
This week’s funding highlights a dual market appetite: deep R&D for novel therapeutics alongside pragmatic healthtech aimed at system efficiency. Investors are backing clinical-stage programmes and discovery platforms as well as tools designed to ease NHS pressures and improve training outcomes.
Mestag Therapeutics raised £30.07 million to advance its FAP-targeted bispecific MST-0312 towards the STARLYS Phase 1 trial and to expand its clinical development team ahead of mid-2026 patient dosing. Flexzo AI secured £9 million to roll out an agentic AI rostering platform across more NHS Trusts and to begin US expansion, aiming to cut agency costs and improve staffing efficiency. Ternary Therapeutics took £3.6 million to advance an AI- and physics-driven platform for designing molecular glue drugs, while Sequential raised £2.63 million to build an AI discovery engine for multi-omic, non-invasive skin testing using its large clinical dataset to accelerate ingredient discovery.
Capital is flowing across Cambridge and London clusters, from clinical-stage biotech to operational healthtech. Investors appear to be balancing the long development timelines of therapeutics with nearer-term deployments that can generate NHS traction, indicating continued portfolio diversification across science-led pipelines and system-facing products.
This week's Health & Biotech deals:
Mestag closed a £30.1m financing to push its FAP-targeted bispecific MST-0312 towards the STARLYS Phase 1 trial and to expand its clinical development team. The round will support the mid-2026 start of patient dosing and further platform and pipeline work in cancer and inflammatory disease.
Flexzo AI raised £9m to roll out its agentic AI rostering platform across more NHS Trusts and begin US expansion. The funding will grow engineering and commercial teams and deepen automation to cut agency costs and improve staffing efficiency.
Ternary raised £3.6m seed to advance an AI and physics‑driven platform for designing molecular glue drugs. The capital will grow research and engineering teams and push its preclinical pipeline towards development milestones.
Sequential secured £2.63m to build an AI discovery engine for multi‑omic, non‑invasive skin testing and next‑generation actives. The round will support development of models using the company's large clinical dataset to accelerate ingredient discovery.
Fintech and risk — niche analytics attract capital
Investors continue to back tools that help institutions and merchants manage evolving forms of financial risk. Demand spans nature-related analytics, Open Finance infrastructure and merchant protection as lenders and retailers seek better data and automation.
Earth Blox raised £6 million to scale an AI-powered nature and climate risk analytics platform for financial institutions and corporates. DataWollet closed £1.3 million to build an Open Finance gateway using neurosymbolic AI and to accelerate product development and commercial expansion. Loxa secured £2.7 million to expand its embedded product protection platform across the EU and to grow its retail partner network, and TradingHub agreed a strategic investment from Nordic Capital to accelerate growth of its trade surveillance platform (financial details were not disclosed).
The pattern is clear: capital is moving into niche risk tools that integrate with existing financial infrastructure. Investors appear comfortable supporting both regulatory-facing analytics and customer-facing merchant products; expect enterprise deals to pick up as these platforms scale beyond early adopters.
This week's Fintech & Risk deals:
Earth Blox raised £6m to scale its AI-powered nature and climate risk analytics platform for financial institutions and corporates. The capital will expand the team and product as demand for nature-related financial risk tools grows.
DataWollet closed a £1.3m pre‑seed to build an Open Finance gateway using neurosymbolic AI. The capital will accelerate product development and commercial expansion while deepening strategic partnerships.
Loxa raised £2.7m to expand its embedded product protection platform across the EU and grow its retail partner network. The funding will support product development and scaling as it aims to become the default checkout protection provider for merchants.
TradingHub agreed a strategic investment from Nordic Capital to accelerate growth of its trade surveillance platform and expand internationally. The parties did not disclose financial details; the deal will support product innovation and global expansion.
Greentech, materials and energy — scaling demos to market
This week’s greentech deals emphasise circular materials and hardware innovations designed to cut lifecycle costs. Investors are funding demonstrations and early manufacturing as companies transition from lab research to commercial deployment.
Cocoon Carbon raised £11 million to commercialise a process that converts electric-arc furnace slag into a cement replacement and to fund a commercial demonstration facility in the US. Regeno secured £420,000 to progress a wind turbine design that can be serviced from ground level, reducing maintenance and installation costs. Hydra Manufacturing took £320,000 to develop production-grade ceramic manufacturing systems that bring scalable ceramic part production in-house.
These rounds show investor support for demonstrators that can prove unit economics and scale. Funding is spread across UK hotspots from London to Glasgow and Leeds, reflecting regional strengths in materials and renewable engineering, and more capital is likely to follow as pilot facilities move towards early commercial deployments.
This week's Greentech, Materials & Energy deals:
Cocoon Carbon raised £11m to commercialise a process that converts electric-arc furnace slag into a cement replacement. The Series A will fund a commercial demonstration facility in the US and support international hiring and scale‑up.
Regeno secured £420k to progress a wind turbine design serviceable from ground level, reducing maintenance and installation costs. The funds will support development and further demonstration work as it prepares for commercialisation.
Hydra Manufacturing raised £320k to develop production‑grade ceramic manufacturing systems that bring scalable ceramic part production in‑house. The capital will support technology development and initial commercial deployments.
Security and defence — cyber and simulation funded in tandem
Funding in security and defence this week covers commercial cyber tools and defence-focused simulation, reflecting demand for faster detection and more realistic training. Investors are supporting companies that promise shorter breach windows alongside spatial AI and simulation for command-and-control.
Tracebit raised £15.03 million in Series A to accelerate development of a security canary platform that shortens breach detection times and to expand enterprise deployments in London and New York. Chorus Intelligence secured £15 million from Maven to speed development of its digital intelligence and investigative platform, supporting AI integration and continued work with law enforcement and government customers. Hadean took £2 million to advance spatial computing and AI simulations for command-and-control training, supporting deployments with the UK Ministry of Defence and expansion to the US.
Collectively, these rounds illustrate appetite for both pure-play cybersecurity and defence tech that can be fielded by public agencies. The crossover is notable as firms pursue commercial contracts alongside government work; expect further deals that bridge enterprise security needs and defence training capabilities.
This week's Security & Defence deals:
Tracebit raised £15m in Series A to accelerate development of its security canary platform that shortens breach detection times. The capital will help expand product capabilities and grow teams in London and New York as the company scales enterprise deployments.
Chorus Intelligence secured £15m from Maven to speed up development of its digital intelligence and investigative platform. The funding will support AI integration, international expansion and continued work with law enforcement and government customers.
Hadean secured £2.1m to advance spatial computing and AI simulations for command‑and‑control training. The investment will accelerate capability development and support deployments with the UK Ministry of Defence and expansion to the US.
🎧 That's this week's Startupmag Weekly Briefing.
See you next Friday for another look at the UK startup scene.